INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

RTTNews | 818 दिनों पहले
INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

(RTTNews) - Biotechnology company INOVIO Pharmaceuticals, Inc. (INO) announced Thursday positive results from a Phase 1b clinical trial evaluating INO-4201, a DNA vaccine candidate, as a booster in healthy adult participants who previously received a single injection of Ervebo.

In the trial, INO-4201 was well-tolerated and boosted humoral responses in 100% (36 of 36) of treated participants.

INO-4201 was evaluated in a 46-participant randomized, placebo-controlled Phase 1b trial (NCT04906629) to assess its safety, tolerability, and immunogenicity in healthy adult participants who previously received a single injection of Ervebo, a vaccine approved by the U.S. Food and Drug Administration for the prevention of disease caused by Zaire ebolavirus in individuals 18 years of age and older.

The participants were dosed with 1 mg of INO-4201 injected intradermally followed by electroporation using our investigational proprietary smart device, CELLECTRA. The trial was designed to test whether INO-4201 can be used as a booster in healthy participants previously vaccinated with Ervebo.

For More Such Health News, visit rttnews.com

टैग: INO
read more
Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Tuesday that it has received feedback from the U.S. Food and Drug Administration (FDA) that data from its completed Phase 1/2 trial of INO-3107 for the treatment of RRP could support INOVIO's submission of a BLA for review under the FDA's accelerated approval program.
RTTNews | 568 दिनों पहले
U.S. GDP Unexpectedly Dips In First Quarter As Imports Soar

U.S. GDP Unexpectedly Dips In First Quarter As Imports Soar

The Commerce Department released a report on Wednesday showing the U.S. economy unexpectedly shrank in the first quarter of 2025. The report said real gross domestic product fell by 0.3 percent in the first quarter after surging by 2.4 percent in the fourth quarter of 2024. Economists had expected GDP to rise by 0.4 percent.
RTTNews | 14 मिनटों पहले
U.S. Private Sector Job Growth Falls Well Short Of Expectations In April

U.S. Private Sector Job Growth Falls Well Short Of Expectations In April

Payroll processor ADP released a report on Wednesday showing private sector employment in the U.S. increased by much less than expected in the month of April. ADP said private sector employment climbed by 62,000 jobs in April after surging by a downwardly revised 147,000 jobs in March.
RTTNews | 38 मिनटों पहले
Eurozone GDP Growth Gains Strength In Q1

Eurozone GDP Growth Gains Strength In Q1

Euro area economic growth accelerated in the first quarter as exports may have benefited from higher demand from the U.S. ahead of the imposition of higher trade tariffs. The quarterly growth in gross domestic product doubled to 0.4 percent from 0.2 percent seen in the fourth quarter of 2024, preliminary flash estimates from Eurostat showed on Wednesday.
RTTNews | 50 मिनटों पहले